![Michael R. Goldberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael R. Goldberg
Keine laufenden Positionen mehr
Profil
Michael R.
Goldberg joined Theravance, Inc. as Vice President of Clinical Pharmacology in September 2005.
From 1988 to 2005, he was Senior Director of Safety/Clinical Risk Management and Safety Surveillance for Merck and worked at Eli Lilly in the Clinical Pharmacology Department.
Dr. Goldberg received his MD and PhD degrees from Tulane University, School of Medicine and completed his Clinical Pharmacology fellowship at the Vanderbilt University School of Medicine.
Ehemalige bekannte Positionen von Michael R. Goldberg
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2005 |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Ausbildung von Michael R. Goldberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
